Evidence map›Paper›PMID 29348441›Full record

ArticleScientific reports2018

SDF1 gradient associates with the distribution of c-Kit+ cardiac cells in the heart.

Outi Renko, Anna-Maria Tolonen, Jaana Rysä, Johanna Magga, Erja Mustonen, Heikki Ruskoaho, Raisa Serpi

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. The Vascular Niche for Adult Cardiac Progenitor Cells.Antioxidants (Basel, Switzerland) · 2022
    Review
  6. Article
  7. Mural Cell SDF1 Signaling Is Associated with the Pathogenesis of Pulmonary Arterial Hypertension.American journal of respiratory cell and molecular biology · 2020
    Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Outi RenkoResearch Unit of Biomedicine, Department of Pharmacology and Toxicology, University of Oulu, Oulu, Finland.
Anna-Maria TolonenResearch Unit of Biomedicine, Department of Pharmacology and Toxicology, University of Oulu, Oulu, Finland.
Jaana RysäSchool of Pharmacy, University of Eastern Finland, Kuopio, Finland.
Johanna MaggaResearch Unit of Biomedicine, Department of Pharmacology and Toxicology, University of Oulu, Oulu, Finland.
Erja MustonenResearch Unit of Biomedicine, Department of Pharmacology and Toxicology, University of Oulu, Oulu, Finland.
Heikki RuskoahoDivision of Pharmacology and Pharmacotherapy, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0001-8971-1359
Raisa SerpiBiocenter Oulu, Faculty of Biochemistry and Molecular Medicine, Oulu Center for Cell-Matrix Research, University of Oulu, Oulu, Finland. raisa.serpi@oulu.fi.
University of Oulu · FIUniversity of Eastern Finland · FIUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Identification of the adult cardiac stem cells (CSCs) has offered new therapeutic possibilities for treating ischemic myocardium. CSCs positive for the cell surface antigen c-Kit are known as the primary source for cardiac regeneration. Accumulating evidence shows that chemokines play important roles in stem cell homing. Here we investigated molecular targets to be utilized in modulating the mobility of endogenous CSCs. In a four week follow-up after experimental acute myocardial infarction (AMI) with ligation of the left anterior descending (LAD) coronary artery of Sprague-Dawley rats c-Kit+ CSCs redistributed in the heart. The number of c-Kit+ CSCs in the atrial c-Kit niche was diminished, whereas increased amount was observed in the left ventricle and apex. This was associated with increased expression of stromal cell-derived factor 1 alpha (SDF1α), and a significant positive correlation was found between c-Kit+ CSCs and SDF1α expression in the heart. Moreover, the migratory capacity of isolated c-Kit+ CSCs was induced by SDF1 treatment in vitro. We conclude that upregulation of SDF1α after AMI associates with increased expression of endogenous c-Kit+ CSCs in the injury area, and show induced migration of c-Kit+ cells by SDF1.

Indexed as

Adult Stem CellsAnimalsBenzylaminesCell MovementCells, CulturedChemokine CXCL12CyclamsDisease Models, AnimalGene Expression RegulationHeart AtriaHeart VentriclesHeterocyclic CompoundsMaleMyocardial InfarctionMyocardiumProto-Oncogene Proteins c-kitBenzylaminesChemokine CXCL12CyclamsHeterocyclic CompoundsplerixaforProto-Oncogene Proteins c-kitReceptors, CXCR4

Identifiers

PMID29348441
PMCPMC5773575
OpenAlexW2784023214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.